Investor's Business Daily on MSN2h
AstraZeneca ADR Scores Relative Strength Rating Upgrade; Hits Key ThresholdAstraZeneca ADR shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 83.
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Zacks.com on MSN1h
TAK or DSNKY: Which Is the Better Value Stock Right Now?But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. There are plenty of strategies for discovering value stocks, but we have found that ...
Donald Trump’s push to restrict US investments in China is testing what in theory should be an ironclad financial ...
Zacks Investment Research on MSN1d
PDD Holdings Inc. Sponsored ADR (PDD) Stock Declines While Market Improves: Some Information for InvestorsIn the latest trading session, PDD Holdings Inc. Sponsored ADR (PDD) closed at $117.77, marking a -0.18% move from the previous day. The stock's change was less than the S&P 500's daily gain of 0.49%.
We recently published a list of Why These 15 Crypto Stocks Have Been Plunging In 2025. In this article, we are going to take ...
Amarin (AMRN) announced its intent to effect a ratio change on its American Depositary Shares from one ADS representing one ordinary share, to ...
2d
No fractional new ADSs will be issued in connection with the Ratio Change. Rather, fractional entitlements to new ADSs will be aggregated and sold by the depositary bank, and the net cash proceeds ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback